Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$55,165,157
-$6,053,679 QoQ
Shares Held
1,655,617
-6.5% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.24530673458898.ToString("F0")%
Shared 0.5894479218321629.ToString("F0")%
None 1.165245343578859.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Derivatives in IDYA
reported options exposure · as of Mar 31, 2026CallValue
$2,665,600
CallShares
80,000
PutValue
$5,930,960
PutShares
178,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. IDYA ranks #48 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in IDYA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,665,600 | 80,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $5,930,960 | 178,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $55,165,157 | 1,655,617 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,218,836 | 1,770,866 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $33,553,004 | 1,233,113 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,816,426 | 1,228,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,369,715 | 816,222 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $45,184,017 | 1,758,133 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $27,535,716 | 869,183 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,760,129 | 676,734 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,381,287 | 418,899 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,897,145 | 278,166 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $11,332,193 | 420,022 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $9,166,856 | 390,079 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,632,438 | 191,729 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,922,298 | 160,831 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,666,876 | 111,721 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,393,675 | 100,991 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,148,334 | 191,987 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,470,497 | 104,505 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,424,482 | 55,884 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $786,578 | 37,474 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $808,870 | 34,420 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $411,376 | 29,384 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $129,669 | 10,324 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,248,803 | 158,255 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $108,615 | 26,363 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||